Polydopamine Nanoparticle Shell for Oxygen Microbubble Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing microbubble dispersion systems stabilized with surfactant molecules are unstable and prone to coalescence, making it difficult to achieve efficient intravenous oxygen supply due to low oxygen carrying capacity and instability.
Innovation Solution
A microbubble dispersion system stabilized with polydopamine nanoparticles is developed, where dopamine is oxidized to form polydopamine nanoparticles that adhere to the interface of oxygen microbubbles, creating a compact shell layer that enhances stability and oxygen delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If surfactant molecules are used to stabilize microbubble dispersion system, then oxygen delivery capability is improved, but system stability deteriorates due to coalescence and Ostwald Ripening
Solution Approach 1:
The patent changes the stabilization mechanism from surfactant-based to polydopamine nanoparticle-based, fundamentally altering the interface properties. Polydopamine nanoparticles form a rigid protective shell that prevents coalescence and suppresses Ostwald Ripening, achieving both stability and oxygen delivery capability simultaneously
Solution Approach 2:
The patent creates a composite structure by coating polydopamine nanoparticles on microbubble surfaces. This composite approach combines the gas-filled microbubble core for oxygen delivery with the polydopamine shell for stability, resolving the contradiction between oxygen delivery and system stability
2Quantity of substance
If microbubble diameter increases due to Ostwald Ripening, then oxygen carrying capacity per bubble is improved, but system stability deteriorates
Solution Approach 1:
The polydopamine nanoparticle shell acts as a pre-established protective barrier that prevents gas diffusion between bubbles. This beforehand cushioning suppresses Ostwald Ripening by blocking the mass transfer pathway, maintaining uniform microbubble size distribution while preserving oxygen carrying capacity
3Stability of the object's composition
If polydopamine nanoparticles are formed by oxidation and polymerization, then microbubble stability is improved, but manufacturing complexity increases
Solution Approach 1:
The patent utilizes the self-polymerization property of dopamine under alkaline conditions. Dopamine automatically oxidizes and polymerizes to form polydopamine nanoparticles in situ on the microbubble surfaces, eliminating the need for complex external polymerization equipment or catalysts, thus achieving simplicity despite the chemical transformation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polydopamine-stabilized microbubble system exhibits excellent biocompatibility, stability, and efficient oxygen delivery, effectively addressing the limitations of traditional systems and providing a reliable method for intravenous oxygen supply.
Implementation Method 1
dopamine is oxidized by oxygen, and polydopamine nanoparticles are adhered to the interface of oxygen microbubbles during polymerization
Implementation Method 2
oxidizing and self-polymerizing the dopamine under alkaline conditions to form polydopamine nanoparticles
Implementation Method 3
polydopamine nanoparticles are adhered to the interface of oxygen microbubbles during polymerization to form a compact shell layer of polydopamine particles
Implementation Method 4
shearing the oxygen into microbubbles by using a high-speed dispersion homogenizer
Implementation Method 5
adding a glutaraldehyde solution into the solution obtained in the step (2), fully mixing with the high-speed dispersion homogenizer, and then stirring to solidify the shell layer of polydopamine particles
Data Source
AI summary
The present application discloses a microbubble dispersion system stabilized with polydopamine nanoparticles for highly-efficient intravenous oxygen supply and a method for preparing the same. The method includes: dissolving dopamine, chitosan quaternary ammonium salt and amino-rich polymer in water, adjusting the pH to be alkaline, and then introducing oxygen into the solution; under the strong shear force of a homogenizer, oxygen oxidizing dopamine, and the obtained polydopamine nanoparticles adhering to the interface of oxygen microbubbles during polymerization, forming a compact shell layer of polydopamine particles; finally, adding glutaraldehyde to solidify the shell layer of polydopamine particles adhered to the interface of microbubbles, and obtaining oxygen microbubbles stably dispersed in water by filtration, washing and redispersion. The oxygen microbubbles stabilized with polydopamine nanoparticles have excellent biocompatibility, can realize rapid and efficient delivery of oxygen, and thus have an important application value in the field of highly-efficient intravenous oxygen supply.